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Abstract
The ADP/ATP carrier protein (AAC) expressed in Artemia franciscana is refractory to bongkrekate. We generated two strains
of Saccharomyces cerevisiae where AAC1 and AAC3 were inactivated and the AAC2 isoform was replaced with Artemia AAC
containing a hemagglutinin tag (ArAAC-HA). In one of the strains the suppressor of DAAC2 lethality, SAL1, was also
inactivated but a plasmid coding for yeast AAC2 was included, because the ArAACDsal1D strain was lethal. In both strains
ArAAC-HA was expressed and correctly localized to the mitochondria. Peptide sequencing of ArAAC expressed in Artemia
and that expressed in the modified yeasts revealed identical amino acid sequences. The isolated mitochondria from both
modified strains developed 85% of the membrane potential attained by mitochondria of control strains, and addition of
ADP yielded bongkrekate-sensitive depolarizations implying acquired sensitivity of ArAAC-mediated adenine nucleotide
exchange to this poison, independent from SAL1. However, growth of ArAAC-expressing yeasts in glycerol-containing
media was arrested by bongkrekate only in the presence of SAL1. We conclude that the mitochondrial environment of
yeasts relying on respiratory growth conferred sensitivity of ArAAC to bongkrekate in a SAL1-dependent manner.
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Introduction
Embryos of the brine shrimp Artemia franciscana exhibit a type of
extremophilia characterized by tolerance of anoxia at room
temperature for several years [1] [2] with no evidence of apoptotic
or necrotic cell death [3]. Protracted anoxia in mammalian species
opens the so-called mitochondrial permeability transition pore
(PTP) [4], [5], [6]. This pore is of a sufficient size (cut-off
,1,5 kDa) to allow passage of solutes and water, causing swelling
and ultimately rupture of the organelle. Activation of the PTP by
Ca2+ overload with the ensuing loss of mitochondrial function
results in a severely diminished capacity for energy production and
is a final common pathway of cell death [7].
Mitochondria isolated from the embryos of Artemia franciscana
lack a Ca2+-induced PTP [8], despite the capacity for a profound
storage for calcium. While the salient components of the PTP have
just been unravelled [9], [10] but see [11] the adenine nucleotide
carrier (AAC) remains a well-established modulatory component
of this pore [12], [13]. All known ligands of the AAC modulate the
probability for PTP opening [12]. Relevant to this, Artemia
franciscana is the only species known in which adenine nucleotide
exchange operated by AAC is refractory to the naturally occurring
inhibitor, bongkrekic acid (BKA) [14]. In species where Ca2+-
induced mitochondrial PTP can be demonstrated, BKA inhibits
adenine nucleotide exchange mediated by the AAC isoforms they
express, and decreases the probability of PTP opening [15], [16],
[17], [12]. Recently however, we have reported that mitochondria
obtained from brown shrimp (Crangon crangon) and common prawn
(Palaemon serratus) exhibit BKA-sensitive mitochondrial adenine
nucleotide transport while lacking a Ca2+-induced permeability
transition [18].
A plausible hypothesis is that AAC interacts with a yet to be
identified protein that initiates PTP opening, and that this protein
interaction is affected by BKA. An obvious impediment in the
elucidation of the role of AAC in PTP and its inhibition by BKA is
the lack of knowledge regarding the binding site of BKA on AAC
[12], [19]. In the AAC protein sequence found in Artemia, the
region between residues 198 and 225 exhibits a low degree of
similarity with AAC sequences from other species [14]. We
therefore postulated that the BKA binding site may reside
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somewhere within this Artemia AAC region. To verify this
hypothesis, a base-by-base alteration is warranted to pinpoint
residues that are critical for the binding of BKA. Insufficient
information regarding the genetic background of Artemia franciscana
prompted us to express Artemia AAC (ArAAC) in a heterologous
environment amenable to genetic manipulations. Yeast is an
excellent platform for such experiments. However, as it will
become evident from the ‘Results’ section below, adenine
nucleotide exchange mediated by heterologously expressed ArAAC
expressed in Saccharomyces cerevisiae was sensitive to BKA. In
addition, due to substitution of endogenous yeast AAC2 carriers
which are also important for cell respiration and viability with
ArAAC, it was necessary to manipulate the presence of the
suppressor of AAC2 lethality, SAL1. SAL1 is required for growth of
yeasts when AAC2 is absent or inhibited by BKA [20]. Contrary to
our expectation, the viability of yeasts expressing ArAAC under
non-fermenting conditions was arrested by BKA only when SAL1
was coexpressed while in the absence of Sal1p, growth of yeasts
expressing ArAAC was BKA resistant. In direct contrast, under
fermenting conditions the viability of yeasts expressing ArAAC was
arrested by BKA only when SAL1 was absent, indicating the
lethality of ArAAC sal1D.
Results
Expression of ArAAC in Yeast Cells
We integrated the ArAAC gene into the locus of the main yeast
AAC gene – AAC2 (Figure 1). As the double aac2 sal1 deletion
strain is lethal and a functional Sal1p is required for growth of
yeast in the presence of BKA which blocks the operation of AAC2
protein [20], the ArAAC was expressed in SAL1 and sal1::NatMX4
deletion background. We first amplified ArAAC using cDNA from
reverse transcribed total Artemia franciscana RNA as template and
cloned it into a TOPO-TA Cloning Vector (TOPO TA CloningH
Kits for Sequencing, Invitrogen). The ArAAC integration cassette
containing the ArAAC-HA tagged gene and the hygromycin
resistance gene HphNTI was constructed as described in ‘Materials
and Methods’. The cassette DNA was transformed into a strain
bearing deletions of two other AAC genes present in yeast, AAC1
and AAC3 (RKY67-1C), resulting in MWY79/15 and MWY79/
17 clones bearing ArAAC-HA gene in the locus of AAC2 (Table 1).
We then deleted the SAL1 gene in control and ArAAC expressing
strains MR6, RKY67-1C and MWY79/15 by transforming them
with sal1::NatMX4 cassette (see under ‘Materials and Methods’),
resulting in strains: MWY85/9, MWY84/3, MWY83/1 and 5
(Table 1). ArAAC could not rescue yeasts in sal1 background, thus
the deletion of SAL1 gene in ArAAC background was done in the
presence of a wild type copy of yeast AAC2 on a Yep352 plasmid
(MWY83 strains). A most appropriate isogenic control for our
ArAAC-expressing constructs would be to reintroduce the AAC2
gene in the same manner, with the HA tag and the resistance gene
cassette in the same positions, as performed in [21] and [22].
However, proteomic analysis of yeast mitochondria expressing
ArAAC verified that the sequence is identical to that expressed in
Artemia franciscana (see below). Moreover, mitochondria from the
MWY79/15 strain, where no endogenous AAC was present,
achieved 85% of total attainable membrane potential, and ADP-
ATP exchange was readily demonstrated (see below). These results
afford a reasonable degree of assurance that the genetic
manipulations in our strains did not confer confounding variables
to the results.
The proper localization of ArAAC protein in mitochondria was
verified by yeast cell extract fractionation, Western blotting and
estimations of citrate synthase activity in the various fractions
(Figure 2). Although there is an extramitochondrial citrate
synthase in yeasts [23], the overall activity is mainly due to that
residing in the mitochondrial matrix. During preparation of the
mitochondria, fractions from the two strains expressing ArAAC
with (MWY79/15) and without (MWY83/1) Sal1p were probed
for the presence of ArAAC (through its HA tag) and porin by
Western blotting and citrate synthase activity. Furthermore,
mitoplasts were also generated from mitochondria and these were
also probed for the presence of ArAAC (through its HA tag) and
porin by Western blotting and citrate synthase activity. The
fractions were: T (total yeast homogenates), S (supernatant), M
(mitochondria), and MP (mitoplasts). The probing for ArAAC
(through its HA tag) and porin was performed in the same blot,
thus the bands appear very close to each other due to the similar
molecular weights of ArAAC and porin. As shown in Figure 2, the
band representing ArAAC in the Western blot and the
corresponding citrate synthase activity in the MP fraction is
greater than the M fraction, but at the same time the band
corresponding to porin in the M fraction is greater than the signal
from the MP fraction. This is consistent with the notion that porin
resides in the outer mitochondrial membrane, which is partially
removed during the preparation of the MP fraction, while ArAAC
is in the inner membrane/matrix side. Thus, ArAAC protein was
expressed and targeted into the yeast inner membrane/matrix
side. The experiments shown below (especially for the strain
MWY79/15 where no endogenous AAC is present) argue that
there was indeed ADP-ATP exchange, and validate the claim that
ArAAC was correctly targeted to the inner mitochondrial
membrane.
Effect of BKA on Viability of the Modified Strains
AAC2 is responsible not only for yeast growth in non-
fermentable sources, termed the respiratory function (R function),
but also possesses an essential role in maintaining cell mitotic
viability on fermentable carbon sources, termed the V function
[24]. Mindful that a functional Sal1p is required for growth of
yeasts when Aac2p is absent or inhibited by BKA [20], we
addressed the function of ArAAC and its response to BKA by
performing growth analysis on fermentable (glucose) and non-
fermentable (glycerol) carbon sources in the presence or absence of
BKA. BKA enters intact yeast cells at pH 4, thus the growth was
tested at this pH [20]. Two different clones harboring the same
genetic manipulations were used in order to gain additional
reinforcement that the observed results were genuine, and not
confounded by the genetic background: therefore, experiments
shown in lanes 4/5, 6/7, and 9/10 harbor the same genetic
manipulations but were performed in different yeast strains (top
table within Figure 3). As shown in Figure 3, yeast cells expressing
AAC2 required a functional SAL1 gene for surviving on glucose-
containing media (V function) in the presence of BKA (compare
lanes 4 and 5 with lane 8 of panels B and C). The strains
expressing ArAAC in lieu of AAC2 also required a functional SAL1
gene for surviving on glucose-containing media in the presence of
BKA, indicating that ArAAC together with the sal1::NatMX4
deletion is lethal (compare lanes 6 and 7 with lanes 9 and 10 in
panels B and C). We confirmed this phenotype by testing the
ability of MWY83 strains to grow on 5-Fluoroorotic Acid (5-FOA)
plates. 5-FOA is converted to a toxic form (i.e., 5-flurouracil) in
strains expressing the functional URA3 gene coding for orotine-5-
monophosphate decarboxylase that is involved in the synthesis of
uracil. Yeast strains that are phenotypically Ura+ become Ura-
and 5-FOA(R) (resistant) after selection. We considered that the
URA3 plasmid-born copy of AAC2 gene in the presence of 5-FOA
in the medium could be lost. However, the MWY83 strains were
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not able to grow on this medium, confirming the ArAAC
sal1::NatMX4 lethality (data not shown). Regarding yeast viability
in glycerol media where cells rely on oxidative phosphorylation (R
function) in relation to SAL1, ArAAC complemented the R function
of yeast AAC2. This can be seen in panels D and E when
comparing the triple deletion lane 1 (where no AAC isoform was
expressed and despite the presence of Sal1p no yeast growth was
observed), and lanes 4 and 5 (where both AAC2 and SAL1 were
expressed), to lanes 6 and 7 (where ArAAC was expressed in lieu of
AAC2). It is noted though, that yeast expressing ArAAC exhibited
slower respiratory growth than those expressing AAC2 (compare
the growth of strains in lanes 1, 4 and 5 with lanes 6 and 7 on
glycerol medium of panels D and E in Figure 3). In the presence of
Sal1p, ArAAC expressed instead of AAC2 conferred sensitivity to
BKA; this is reflected in lanes 6 and 7 of panel F, whereas in the
absence of Sal1p, it conferred resistance to BKA, inferred from the
growth of cells shown in lanes 9 and 10 of panel F where ArAAC
and AAC2 (from the plasmid) were expressed. Because sal1 yeasts
expressing ArAAC can grow in the presence of BKA in glycerol
but not glucose media, we concluded that ArAAC could not
complement the viability (V) function of yeast Aac2p.
Adenine Nucleotide Exchange Mediated by Yeast-
expressed ArAAC is Sensitive to BKA
To test the effect of BKA on ADP/ATP exchange by ArAAC
expressed in yeasts, we relied on the electrogenic property of the
carrier during adenine nucleotide exchange. Mitochondria isolat-
Figure 1. ArAAC integration cassette including coding sequence of ArACC gene fused to HA tag and hygromycin cassette (HphNTI)
flanked by promoter and terminator sequences of yeast AAC2 gene. The order of PCR reactions is described in ‘Materials and Methods’
section. The positions of the primers used for PCR reactions (marked by numbers corresponding to the numbered primers listed in Table 2) and the
length of DNA fragments are also indicated.
doi:10.1371/journal.pone.0074187.g001
Table 1. Strains used in this work.
Strain Nuclear genotype Source
MR6 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 arg8::HIS3 [63]
RKY67-1C MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 arg8::HIS3 aac1DKanMX4 aac3DKanMX4 AAC2 This study
RKY67-1D MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 arg8::HIS3 aac1DKanMX4 aac3DKanMX4 AAC2 This study
MWY80 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 arg8::HIS3 aac1DKanMX4 aac3DKanMX4 aac2DHphNTI This study
MWY85/9 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 arg8::HIS3 sal1D::NatMX4 This study
MWY79/15 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 arg8::HIS3 aac1DKanMX4 aac3DKanMX4 aac2D::ArAAC-HA-
HphNTI
This study
MWY79/17 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 arg8::HIS3 aac1DKanMX4 aac3DKanMX4 aac2D::ArAAC-HA-
HphNTI
This study
MWY84/3 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 arg8::HIS3 aac1DKanMX4 aac3DKanMX4 sal1D::NatMX4 This study
MWY83/1 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 arg8::HIS3 aac1DKanMX4 aac3DKanMX4 aac2D::ArAAC-HA-
HphNTI sal1D::NatMX4 [AAC2/pYep352]
This study
MWY83/5 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 arg8::HIS3 aac1DKanMX4 aac3DKanMX4 aac2D::ArAAC-HA-
HphNTI sal1D::NatMX4 [AAC2/pYep352]
This study
doi:10.1371/journal.pone.0074187.t001
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ed from the yeast strains detailed below were energized by ethanol,
and the effect of BKA during ADP-induced depolarization was
evaluated by recording membrane potential (m) with rhodamine
123. To calibrate the rhodamine fluorescence signal, at the end of
all experiments the uncoupler SF 6847 (SF, 1 M) was added to
induce complete depolarization. The yeast strains used for these
experiments are shown in the table on the top of Figure 4. As
shown, they either express AAC2 plus SAL1 (RKY67-1C), or
ArAAC plus SAL1 (MWY79/15) or only AAC2 (MWY84/4) or
ArAAC plus AAC2 from a plasmid (MWY83/5). Because BKA
needs to be protonated in order to exert its action on the carrier
[25], [26], it becomes less effective at increasing pH. We therefore
tested the effect of BKA versus its vehicle (NH4OH) in the pH
range of 7.1–7.4. Isolated mitochondria (1 mg) were added in a
buffer the composition detailed in ‘Materials and Methods’ with a
pH indicated in the panels of Figure 4, in the presence of
rhodamine 123 (0.5 M). Ethanol (20 l of 96%) was immediately
added in order to energize mitochondria, and this was reflected by
a decrease in rhodamine fluorescence. In ArAAC-expressing cells
(green or magenta traces) there was a 15% decrease in
mitochondrial polarization as compared to other strains (black
or grey traces). After 50 sec, 2 mM ADP was added as indicated in
Figure 4, resulting in an immediate depolarization due to the
electrogenic exchange of ATP42 for ADP32 through the adenine
nucleotide carrier. As soon as a new plateau of m was established,
BKA (1 M) or NH4OH (1 mM) was added as indicated in
Figure 4. In accordance with the results reported previously [14],
NH4OH exerted a minor depolarizing effect. It is also apparent
from all panels that mitochondria obtained from all strains
exhibited BKA-induced repolarizations. As expected, the extent of
BKA-induced repolarization was dependent on pH, but even at a
condition at pH 7.4 where BKA had only a minimal effect on
Aac2p-mediated adenine nucleotide exchange (black trace bottom
right), it potently abolished ADP-induced depolarization in ArAAC-
expressing mitochondria (same panel, green trace). Since BKA
induced repolarization in mitochondria obtained from all strains,
we concluded that the ArAAC expressed in yeasts became sensitive
to BKA. Moreover, in contrast to the viability results shown above,
ArAAC was sensitive to BKA in a manner independent of SAL1.
Mass-spectrometry of Mitochondria Isolated from
Artemia Franciscana Embryos and from Yeasts Expressing
ArAAC
The apparent discrepancy between the above observation
showing sensitivity of ArAAC expressed in yeasts to inhibition by
BKA, while Artemia mitochondria are refractory to this poison
[14], prompted us to investigate if ArAAC expressed in yeast is
indeed identical to that expressed in Artemia. To answer this
question, we performed mass spectrometric analysis of isolated
mitochondria from strain MWY79/15 expressing the ArAAC, and
from isolated mitochondria from embryos of Artemia franciscana, see
Table S1 in the Supplemental Material. Samples were treated as
detailed in ‘Materials and Methods’. As shown in Figure 5, we
detected 62% sequence coverage of the ArAAC protein expressed
in yeast mitochondria, and 70% of the ArAAC found in Artemia.
Despite the fact that sequence coverage was not 100%, peptide
fragments of ArAAC expressed in either yeasts or Artemia were
detected near the N- and C-termini, arguing against a truncated
form of ArAAC expressed in yeasts. By comparing the ArAAC
expressed in yeasts to that expressed in Artemia, it could be
concluded that the proteins are identical. The homologues of
Sal1p, SCaMC-2 (isoform 1) and SCaMC-3 were identified in the
mass spectrometric analysis of the Artemia mitochondria (see Excel
Sheet S1 in the Supplemental Material). However, the searches of
the spectra obtained by mass spectrometry were made using the
mouse MitoCarta database [27]. Ongoing efforts are under way to
sequence the transcriptome of Artemia franciscana which would be
optimal for correctly identifying all proteins from the Artemia
mitochondria peptide fragments detected by mass spectrometry.
Discussion
We investigated the effect of heterologously expressing AAC of
Artemia franciscana in Saccharomyces cerevisiae. The most important
findings of this study are as follows: i) respiratory growth of yeasts
expressing ArAAC was arrested by BKA only when SAL1 was
coexpressed; ii) fermentative growth of yeasts expressing ArAAC
was arrested by BKA only when SAL1 was absent, and iii) adenine
nucleotide exchange mediated by ArAAC expressed in yeasts
became sensitive to BKA, in a manner independent of SAL1.
In order to explain the sensitivity of adenine nucleotide
exchange mediated by ArAAC expressed in yeasts to BKA, the
challenge of reconciling two findings emerges: the first is that
ArAAC expressed in Artemia franciscana is refractory to BKA [14],
[18] and the second is that BKA binds directly on the carrier [28],
[29], [reviewed in [12]], making it unlikely that an as yet to be
identified protein conferring AAC sensitivity to BKA is absent in
mitochondria from Artemia franciscana. However, the opposite
scenario seems possible: that an as yet to be identified protein
conferring ArAAC resistance to BKA is present in mitochondria
from Artemia franciscana. As mentioned in the ‘Results’ section,
ongoing efforts are under way to sequence the transcriptome of
Artemia franciscana which would allow the identification of more
proteins from the Artemia mitochondria peptide fragments. After
this database is assembled, proteins interacting with ArAAC
expressed in Artemia mitochondria can be sought.
The acquired sensitivity of ArAAC expressed in yeast to BKA
outlines a limitation in a common strategy of heterologously
Figure 2. The ArAac protein is expressed and targeted to yeast
mitochondria. Total extract (T), mitochondrial (M), post-mitochondrial
supernatant (S) and mitoplast (MP) fractions were prepared from strains
expressing heterologous Artemia Aac proteins as indicated in the table
on the top: ‘no’ signifies absence of the gene indicated in the left-most
column; ‘Yes’ signifies the presence of the gene indicated in the left-
most column. Samples of 25 mg of each fraction were separated on 10%
polyacrylamide gel electrophoresis. Blots were probed for ArAAC (HA
tag) and porin in the same solutions. The Western blot results shown
are typical from three independent experiments. In the lower bar graph,
citrate synthase activities of the same fractions are depicted.
doi:10.1371/journal.pone.0074187.g002
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expressing proteins in this organism for the purpose of genetic
manipulation; it is neither necessary nor expected for a heterol-
ogously expressed protein to behave exactly like in its native
environment. Relevant to this, the lipid environment in which
AAC is embedded is a critical component for exchange activity in
both yeast and mammals [30], [31], [32]. Indeed, a high sensitivity
of yeast AAC2 to the cardiolipin content has been previously
demonstrated [33], [34]. The lipid composition of the inner
mitochondrial membrane of Artemia in which AAC is embedded
may be very different from that in yeasts or any other organism to
the extent that affords BKA resistance.
The ArAAC-SAL1 interaction suggests a departure from what
has been established for AAC2-SAL1 interaction: in yeast cells with
no AAC2 expression the presence of SAL1 is required for survival in
glucose-containing media and vice versa [24]. This is because
besides the respiratory function, AAC2 exhibits an essential role for
maintaining cell mitotic viability on fermentable carbon sources;
co-inactivation of SAL1 and AAC2 leads to defects in mitochondrial
translation and mitochondrial DNA (mtDNA) maintenance [35].
In the results presented above, ArAAC-expressing yeasts in lieu of
AAC2 and also coexpressing SAL1 failed to exhibit respiratory
growth in the presence of BKA; on the other hand, coexpression of
SAL1 in ArAAC-expressing yeasts in lieu of AAC2 in glucose-
containing media rescued cell growth from BKA. In the absence of
BKA, expression of ArAAC in lieu of AAC2 did not result in growth
arrest irrespective of SAL1 and independent from growth
conditions. These results suggest that ArAAC restored the R
function but not the V function, originally attributed to AAC2.
Based on the observations that Sal1p allowed yeast growth in
the presence of bongkrekic acid on respiratory media, while BKA
blocked ADP-ATP exchange in isolated mitochondria from the
same strains, one might propose that Sal1 prevents BKA from
hindering AAC in maintaining growth during respiratory condi-
tions in a manner unrelated to adenine nucleotide exchange. This
conclusion is at odds with earlier reports with yeast mutants
exhibiting BKA resistance during respiration [36], in view of the
presumption that these strains possessed Sal1p in their mitochon-
dria. The reason(s) for this discrepancy is unknown; however, the
exact role of Sal1p regarding yeast viability has not been
unequivocally determined and is discussed below.
Sal1p mediates a Ca2+-dependent import of ATP-Mg from the
cytosol to the mitochondria under conditions where these
organelles are ATP consumers [37], [38], thereby maintaining
or promoting cell survival. The mammalian homologue SCaMC
(small calcium-binding mitochondrial carrier protein) also operates
as a Ca2+-dependent ATP-Mg/Pi carrier. It has been shown that
SCaMC-1 promotes cancer cell survival by desensitizing mito-
chondrial permeability transition via ATP/ADP-mediated matrix
Figure 3. Viability of modified and control yeast strains in response to BKA (1 M for the glucose-containing plates, and 20 nM for
the glycerol-containing plates). Yeast strains were grown on media indicated in the panels in the absence or presence of BKA at 28uC. Each lane
contains spots with initially 106, 105, 104, 103 and 102 cells (top to bottom). The genotypes of the strains are given in the table shown on the top of
the figure: ‘no’ signifies absence of the gene indicated in the left-most column; ‘Yes’ signifies the presence of the gene indicated in the left-most
column. 1 (MWY80) - aac1D aac2D aac3D, 2 (MWY85/9) - sal1D, 3 (MR6) – WT, 4 (RKY67-1C), 5 (RKY67-1D) – two independent clones aac1D aac3D
AAC2, 6 (MWY79/15), 7 (MWY79/17) - two independent clones aac1D aac3D ArAAC, 8 (MWY84/4) - aac1D aac3D AAC2 sal1D, 9 (MWY83/5), 10
(MWY83/1) - two independent clones aac1D aac3D ArAAC sal1D [AAC2]. Plates were scanned after 4 (glucose) or 6 (glycerol) days of incubation.
doi:10.1371/journal.pone.0074187.g003
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Ca2+ buffering [39]. SCaMC-3 is critical for the increase in
oxidative phosphorylation in rodent liver mitochondria in
response to glucagon and Ca2+-mobilizing agents, an effect that
that was likely due to allowing Ca2+-dependent accumulation of
mitochondrial adenine nucleotides [40]. Furthermore, although it
has not been explicitly sought, the presence of SCaMC isoforms in
the livers of transgenic mice engineered to lack their own adenine
nucleotide carriers is probably the reason why these mice did not
exhibit embryonic lethality [13]. However, the requisite nature of
SCaMC in mammalian systems has not been attributed to
maintenance of matrix adenine nucleotide levels. Likewise, in
yeast it has not been established if Sal1p complements for Aac2p
by means of transporting adenine nucleotides, hence the opposing
conclusions by the groups of Chen and Kolarov [35], [20].
Nonetheless, yeast as a model system enjoys greater versatility
because its growth can be examined during fermenting (V
function) versus respiratory (R function) conditions. With such a
comparison, we addressed the contribution of SAL1 and AAC2.
The availability of our yeast strains expressing ArAAC in lieu of
AAC2 and the effects it exhibits in relation to SAL1 may help to
elucidate the role of SAL1 to cell survival.
Finally, mindful that mitochondria obtained from Artemia
franciscana do not exhibit the Ca2+-induced PTP [8], it would be
desirable to test yeast mitochondria expressing ArAAC for Ca2+-
induced PTP. Unfortunately, Saccharomyces cerevisiae do not express
the mitochondrial calcium uniporter [41], [42], [43], even though
they exhibit a channel with characteristics reminiscent of PTP,
known as ‘yeast mitochondrial unselective channel’ (YMUC) [44].
Materials and Methods
Strains and Genotypes
The S. cerevisiae strains and their genotypes are listed in Table 1.
Construction of Yeast Strains
To construct AAC1 and AAC3 deletions in MR6 background the
aac1::KanMX4 and aac3::KanMX4 cassettes were amplified by PCR
using as templates total DNA isolated from strains bearing
deletions of AAC1 and AAC3 genes from the EUROSCARF
collection. MR6 strain was transformed with the deletion cassettes
as described previously [45] and transformants were selected on
YPGA medium supplemented with 200 mg/ml geneticin G418.
The correct integration of the cassettes was verified by PCR using
AAC1Ver, AAC3Ver and KanMX-Up primers, and by pheno-
typic analysis. The RKY67-1C double aac1::KanMX4 aac3::K-
anMX4 strain was constructed by crossing the single deletion
strains aac1::KanMX4 and aac3::KanMX4, sporulation of the diploid
AAC1/aac1::KanMX4 AAC3/aac3::KanMX4 strain followed by
tetrad dissection. To integrate ArAAC into yeast genome the
ArACC gene was first amplified with primers ArAnt F and ArAnt R
(all primers are listed in Table 2) using cDNA from reverse
transcribed total Artemia franciscana RNA as template and cloned
into TOPO-TA Cloning Vector. The ArACC cassette for
integration into yeast DNA was constructed by multiple PCR
reactions; all cloning steps were verified by sequencing [46]. The
cassette included ArACC-HA and HphNTI genes flanked by yeast
ACC2 gene promoter and terminator sequences, see Figure 1. The
HA, HphNTI, AAC2 gene promoter and terminator sequences were
amplified separately using pYM16 or total DNA from yeast as
templates, respectively. Before the HphNTI gene the sequences of
ADH terminator and TEF promoter are present [46]. The AAC2
gene promoter was then fused to HA by one PCR reaction
(product A), HA was fused to ADH terminator and HphNTI gene
by a second PCR reaction (product B) and HA and HphNTI gene
were fused to AAC2 gene terminator in a third PCR reaction
(product C). The final PCR product was assembled using products
A, B and C as templates and cloned into pGEM T-easy vector
resulting in plasmid pMW77/11. The EcoRV restriction site was
engineered before the HA tag sequence. The ArACC gene was
amplified from the pCR 2.1-TOPO vector (Invitrogen) using
primers 9upANT and 10upANT, introducing EcoRV restriction
sites. The 915-bp product digested by EcoRV was cloned into
EcoRV site of pMW77/11 resulting in pMW83 plasmid. The
integration cassette was cut off from pMW83 by XbaI enzyme and
used to transform RKY67-1C strain. Transformants were selected
on YPGA medium supplemented with 300 mg/ml hygromycin B.
Homologous integration of ArACC in MWY79/15 strain was
verified by PCR using primers AAC2veri and AAC2lov and by
phenotypic analysis. To construct sal1::NatMX4 deletion, the SAL1
coding sequence and its promoter and terminator region
(2193 bp upstream and 226 bp downstream) was PCR-amplified
Figure 4. The ArAac protein expressed in yeasts is sensitive to
BKA. In the table on top the yeast strains and their expression of
adenine nucleotide carriers and SAL1 is indicated; ‘no’ signifies absence
of the gene indicated in the left-most column; ‘Yes’ signifies the
presence of the gene indicated in the left-most column. In the panels,
reconstructed time courses of rhodamine 123 fluorescence (expressed
as % of m) as functions of time are shown. In the top three panels
mitochondria from strains RKY67-1C (black and grey traces) and
MWY79/15 (green and magenta traces) express SAL1. In the bottom
three panels, mitochondria from strains MWY84/4 (black traces) and
MWY83/5 (green traces) do not express SAL1. The pH of the media is
indicated on the top of each panel. EtOH signifies ethanol.
doi:10.1371/journal.pone.0074187.g004
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using primers Sal1-Up and Sal1-Low. The PCR product was
cloned into pJet vector resulting in pMW100/6 plasmid. The
construct sal1D::NatMX4 gene and the PvuII/EcoRV fragment
from plasmid pAG25 [47] including NatMX4 drug resistance gene
was cloned into KpnI blunt-ended with Klenow and EcoRV sites of
SAL1 gene on pMW100/6 plasmid resulting in pMW105/5
plasmid. A linear DNA fragment including sal1D::NatMX4 cassette
was cut off from this plasmid and introduced by transformation
into RKY67-1C and MWY79/15 strain bearing the wild type
yeast AAC2 gene on a Yep352 URA3 plasmid. Transformants
were selected on YPGA medium supplemented with nourseothri-
cin (nat), 100ug/ml. Homologous integration of sal1::NatMX4
cassette in MWY84/3 and MWY83/5 strains was verified by PCR
using the primers SalVerif and SalR and by phenotypic analysis.
Growth and Media
The media used for yeast growth were: YPGA (1% (w/v) yeast
extract, 1% (w/v) peptone, 2% (w/v) glucose, and 40 mg/liter
adenine); N3 (1% (w/v) yeast extract, 1% (w/v) peptone, 2% (w/v)
glycerol; YPGALA (1% (w/v) yeast extract, 1% (w/v) peptone, 2%
(w/v) galactose, and 40 mg/liter adenine); W0 (0.17% (w/v) yeast
nitrogen base without amino acids, 2% (w/v) glucose, amino acids,
adenine and uracil (media manufactured by Sunrisescience,
Erpent, Belgium). Solid media contained 2% (w/v) agar. The
YPGA or YPGLY BKA plates additionally contained 50 mM
sodium citrate, BKA 1 mM (if yeasts were grown on glucose) or
0.02 mM (if yeasts were grown on glycerol) where indicated, and
the pH 4 was adjusted by 1 M citric acid. For mitochondrial
isolation yeast cells were cultured to the mid-logarithmic phase on
YPGALA medium (OD=4) at 28uC while shaking at 180 rpm.
The 5-FOA plates contained W0 medium supplemented with all
required amino acids and 0,1% 5-fluooroorotic acid.
Yeast Mitochondrial Isolation
Mitochondria from the yeast strains were prepared as described
previously [48]. Typical yield was,20 mg of mitochondria from 2
liters of yeast cultures (OD=4). Protein was determined by the
method of Lowry.
Isolation of Mitochondria from Artemia Franciscana
No permits were required for the described study, which
complied with all relevant regulations. Mitochondria from
embryos of Artemia franciscana were prepared as described
elsewhere, with minor modifications [2]. Dehydrated, encysted
gastrulae of Artemia franciscana were obtained from Salt Lake, Utah
through Artemia International LLC (Fairview, Texas 75069, USA)
and stored at 4uC until used. Embryos (15 g) were hydrated in
0.25 M NaCl at room temperature for at least 24 h. After this
developmental incubation, the embryos were dechorionated in
modified antiformin solution (1% hypochlorite from bleach,
60 mM NaCO3, and 0.4 M NaOH) for 30 min, followed by a
rinse in 1% Na+-thiosulfate (5 min) and multiple washings in ice-
cold 0.25 M NaCl as previously described [49]. After the embryos
were filtered through filter paper,,10 g were homogenized in ice-
cold isolation buffer consisting of 0.5 M sucrose, 150 mM KCl,
1 mM EGTA, 0.5% (wt/vol) fatty acid-free BSA, and 20 mM K+-
HEPES, pH 7.5, using a glass-Teflon homogenizer at 850 rpm for
ten passages. The homogenate was centrifuged for 10 min at
300 g at 4uC, the upper fatty layer of the supernatant was
aspirated and the remaining supernatant was centrifuged at
11,300 g for 10 min. The resulting pellet was gently resuspended
in the same buffer, avoiding the green core. The green core was
discarded, and the resuspended pellet was centrifuged again at
11,300 g for 10 min. The final pellet was resuspended in 0.4 ml of
ice-cold isolation buffer consisting of 0.5 M sucrose, 150 mM KCl,
0.025 mM EGTA, and 20 mM K+-HEPES, pH 7.5 and con-
tained ,80 mg protein/ml.
Determination of Mitochondrial Membrane Potential (m)
m of isolated yeast mitochondria was estimated as described
previously [50], by monitoring the quenching of rhodamine 123
fluorescence (0.5 mM) using a lex of 485 nm and a lem of 533 nm
Figure 5. Primary sequence coverage of ArAAC expressed in yeast and ArAAC expressed in Artemia franciscana as determined from all
mass spectrometry experiments described in ‘Materials and Methods’. Sequence coverage was based on searching peptide tandem spectra
against the Artemia franciscana protein from NCBI, as described in the text. A: Primary sequence coverage of Artemia franciscana adenine nucleotide
translocator protein (gi|308390607) expressed in Artemia franciscana. 70% Sequence coverage was obtained by identifying 210/301 residues (green)
in the protein. B: Primary sequence coverage of Artemia franciscana adenine nucleotide translocator protein (gi|308390607) expressed in
Saccharomyces cerevisiae (strain MWY79/15). 62% Sequence coverage was obtained by identifying 188/301 residues (green).
doi:10.1371/journal.pone.0074187.g005
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at an acquisition rate of 10 Hz with a Cary Eclipse Fluorescence
Spectrophotometer (Agilent Technologies, Santa Clara, CA, USA)
during constant stirring. 1 mg of yeast mitochondria was added in
a 2 ml buffer consisting of 0.65 M mannitol, 0.36 mM EGTA,
1 mM MgCl2, 15 mM Trizma, 11 mM NaH2PO4, and 10 mM
malate; the pH was set in a range of 7.1–7.4 as detailed in the
Results section. All experiments were performed at 28uC.
Determination of Citrate Synthase Activity
Citrate synthase activity for the fractions obtained during
mitochondrial and mitoplast isolations was performed as detailed
in [51]. Citrate synthase specific activity is expressed as nmol of
DTNB (5,59-dithiobis-(2-nitrobenzoic acid) reduced to NTB (2-
nitro-5-thiobenzoate) per min per mg of protein. Mitoplasts were
generated by subjecting 10 mg of mitochondria in a 2 ml buffer
composed of 20 mM Tris pH 6.8 for 30 min, in the presence of
0.05% digitonin. After spinning at 10,000 g for 10 min, the
supernatant was removed, and the pellet consisting of mitoplasts
was resuspended in 0.1 ml of the same buffer.
Western Blotting
SDS-PAGE was performed according to Laemmli [52], with the
modifications elaborated in [53]. Monoclonal anti-HA antibody
(16B12) against HA tag (Berkeley Antibody Company, Richmond,
CA, USA) was used at a 1:5,000 dilution. Rabbit polyclonal anti-
porin was used at a 1:10,000 dilution. Immunoreactivity was
detected in the nitrocellulose papers using peroxidase-linked
secondary antibodies (1:10,000, DAKO, Agilent Technologies)
Table 2. Oligonucleotides used in this work.
Oligonucleotide Sequence Goal
AAC1Up GCGACTCAGCGTACGTAGG AAC1 deletion
AAC1Low CGTAAACGGTTCCCTTCCGC AAC1 deletion
AAC1Ver ACTACATGCACGAGGCCTTGGC AAC1 deletion verification
AAC3Up TTTCATTGTTTGGTTGCCTTC AAC3 deletion
AAC3Low ATCCAACCATCTGAAAGCCG AAC3 deletion
AAC3Ver GCTTCCAATGGCCTCCTCACCG AAC3 deletion verification
KanMX-Up GGATGTATGGGCTAAATGTA AAC3 deletion verification
ArAnt F: ATG GCA ACC AAG AAG CAA GCG G ArACC amplification
ArAnt R: CTA ACC AAT AAG CAC
TTT AAG CTC
ArACC amplification
1 ANTcon GTCTAGAAACATCACGATGC
ACGAGCACTGT
ACC2 promoter amplification
2 ANTcon GTAAGCGTAATCTGGAACATCGTATGGGTAGATATCGGC
TATTTGCTTATATGTATGTTAATG 39
ACC2 promoter amplification
3 ANTcon CAT TAA CAT ACA TAT AAG CAA ATA GCCGAT ATC
TAC CCA TAC GAT GTT CCA GAT TAC GCT TACCC
HA tag encoding
sequence amplification
4 ANTcon CATAAATCATAAGAAATTCGCTTATTTAGAAGTGCTAA
GCGTAATCTGGAACATCGTATGGGTA
HA tag encoding
sequence amplification
5 ANT con CCCATACGATGTTCCAGATTACGCTTAGCACTTCTAAAT
AAGCGAATTTCTTATGATTTATG
HphNTI gene sequences
amplification
6 ANT con GATTAAGAATCAAGCCAGATTAGACTTATTCCTTT
GCCCTCGGACGAGTGCTG
HphNTI gene sequences
amplification
7 ANT con CAGCACTCGTCCGAGGGCAAAGGAATAAGTCTA
ATCTGGCTTGATTCTTAATC
ACC2 terminator amplification
8 ANT con GTCTAGACGGCACAAAGAG
TGATAGACCTATTTGGC
ACC2 terminator amplification
9upANT CGATATCATGGCAACCAA
GAAGCAAGCGGATCCCCTC
ArACC gene amplification
10forANT CGATATCACCAATAAGC
ACTTTAAGCTCGTCATAGAA
ArACC gene amplification
AAC2veri AACATCACGATGCACGAGCACTG Cassette integration verification
AAC2low GAGTGATAGACCTATTTGGCGGTG Cassette integration verification
Sal1-Up CAGGCAATTAACCTTGTGTTT
CTGACG
SAL1 gene amplification
Sal1-Low CCACAAACCGCAGCAGCGG
TTTATAA
SAL1 gene amplification
SalVerif GTTCCAACTTGGGCATTTTTCAGAG Sal1::NatMX4 integration
verification
SalR CCACAAACCGCAGCAGCGG
TTTATAA
Sal1::NatMX4 integration
verification
Restriction sites for XbaI and EcoRI sites are underlined.
doi:10.1371/journal.pone.0074187.t002
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and enhanced chemiluminescence detection reagent (Immobilon
Western Chemiluminescent HRP Substrate, Millipore).
Mass Spectrometry: Yeast Mitochondria
2 ml of yeast mitochondria (6 mg/ml) containing 5 pmol beta-
lactoglobulin as an internal standard was incubated for 30 min at
60uC with 1 ml reagent mixture containing 0.33 w/w% RapiGest
SF and 33 mM dithiothreitol in a total volume of 20 ml. This was
followed by alkylation for 30 min in the dark at room temperature
in the presence of 1 ml 200 mM iodoacetamide and 5 ml 200 mM
NH4HCO3. Digestion was performed either by trypsin (1 ml,
20 mM) at 37uC for 90 min or 180 min or by chymotrypsin (1 mL,
39 mM) at 37uC for 90 min or overnight. Digestion was quenched
by 1 ml formic acid (30 min at 37uC) and the reaction product was
centrifuged at 17,000 g for 10 min. The sample was diluted two
times prior to analysis and a 2 mL sample was injected on to the
capillary LC column. LC–MS/(MS) experiments were carried out
using a nanoflow UPLC system (nanoAcquity UPLC, Waters,
Milford, MA, USA) coupled to a Q-TOF Premier mass
spectrometer (Waters, Milford, MA, USA). Before separating the
peptides on a reverse phase analytical column (C18, 75 mm i.d.6
150 mm, 1.7 mm BEH300 particles, Waters, Milford, MA, USA),
samples were desalted online on a Symmetry C18 trap column
(180 mm i.d.6 20 mm, Waters, Milford, MA, USA). A gradient
was applied using a ow rate of 450 nanol/min and column
temperature 55uC for 100 or 200 min, as described previously
[54] using aqueous and acetonitrile-containing solvents, both in
the presence of 0.1% formic acid. Peptides were identified by
tandem mass spectrometry in two separate data dependent
acquisition modes (DDA). In the first case 2 sec cycles were used,
consisting of a full scan spectrum (m/z: 500–1999) and MS/MS
spectra of the three most abundant ions. In the second case 3 sec
cycles were applied, consisting of a full scan spectrum (m/z: 400–
1500) and MS/MS spectra of the three most abundant ions
included in the predefined inclusion list. The inclusion list
contained the masses of the expected tryptic or chymotryptic
peptides of ArAAC. Ar collision gas was used in the tandem mass
spectrometry measurements. ProteinLynx Global Server v.2.3
(Waters, Milford, MA, USA) was used to process data of DDA
experiments. Mascot Server version 2.2 (Matrix Science, London,
UK) was used to analyze samples searching against Artemia
franciscana taxonomy assuming digestion enzymes trypsin or
chymotrypsin and allowing for two missed cleavages. Iodoaceta-
mide derivatives of cysteines and oxidation of methionines were
specified as fixed and variable modifications, respectively. Frag-
ment ion mass tolerance of 0.15 Da and a parent ion tolerance of
50 ppm were used and peptides were considered if they could be
established at greater than 95.0% probability. To identify further
peptide fragments, additional error-tolerant Mascot searches were
performed against Artemia franciscana taxonomy.
Sample Preparation for Artemia Franciscana
Mitochondria Lysed in RIPA Buffer
Artemia franciscana mitochondria in RIPA (radioimmunoassay)
buffer were thawed and centrifuged at 16,000 g for 10 min. The
pellet was solubilized in 5 M urea, 2 M thiourea, 40 mM DTT
and 0.1% SDS, and both the pellet and the supernatant were
cleaned up using the GE Healthcare 2-D Clean-Up Kit per the
manufacturer’s instructions (GE Healthcare Bio-Sciences Corp.,
Piscataway NJ). After the clean up, the pellets were extracted with
100 mM ammonium bicarbonate, pH 7.8 and sonicated for
10 min in a bath sonicator. After centrifugation, the extraction
and sonication steps were repeated on pellets still remaining.
Supernatants were combined and the protein concentration was
determined using the Pierce 660 nm assay as per the manufac-
turer’s instructions (Pierce, Rockford IL). Three 60 g protein
portions were electrophoresed by SDS-PAGE using a 7 cm 10%
Mini-Protean TGX gel from BioRad (BioRad, Hercules CA) and
stained with BioSafe Coomassie Blue (BioRad, Hercules CA). The
gel lanes were digested with trypsin following reduction with DTT
and alkylation with iodoacetamide, followed by peptide extraction
from the gel lane [55]. The peptide digest was cleaned up using
Spec-C18 cartridges (Varian, Lake Forest, CA).
LC-LC-MS/MS Analysis of the RIPA-lysed Mitochondria
For LC-LC-MS/MS analysis, a microbore HPLC system
(Surveyor, Thermo Fisher Scientific, San Jose, CA) was used with
separate strong cation exchange (SCX) and reversed phase (RP)
columns: a 100 mm I.D. capillary packed with 3.5 cm of 5 mm
PolySulfoethyl-Asp strong cation exchanger (PolyLC Inc., Colum-
bia, MD) and a separate 100 mm I.D. capillary packed with
7.5 cm of 5 mm Zorbax Eclipse XDB-C18 material (Agilent, Santa
Clara, CA). Peptides were acidified using trifluoroacetic acid and
30 g was manually loaded by pressure packing onto the SCX
column. Peptides were eluted at 400 nl/min by a reverse phase
gradient using Buffer A (water/0.1% formic acid), Buffer B
(acetonitrile/0.1% formic acid), preceded by a salt bump using
Buffer C (250 mM ammonium acetate), and Buffer D (1.5 M
ammonium acetate). Twelve steps were then performed as follows:
(step 1) 0% C with an RP gradient of 5–50% B over 90 minutes
followed by a column clean-up of 5 minutes using 50–98% B and
an equilibration of 20 min with 5% B. (steps 2–11) X% C (where
X=10–100% C increased in increments of 10%; the remaining %
was Buffer A) loaded over 4 min and then washed with 5% B for
7 min followed by a RP gradient of 5–50% B over 60 min. Each
RP gradient was followed by a column clean-up of 5 min using
50–98% B and an equilibration of 20 min with 5% B. Step
12:50% D loaded over 4 min and then washed with 5% B for
7 min followed by a gradient of 5–50% B over 60 min. The flow
rate was 1000 nl/min for the 7-minute washes following each salt
bump and for each final 5% B equilibration step. Peptides were
directly sprayed into a ThermoFinnigan LTQ linear ion trap mass
spectrometer (Thermo Fisher Scientific, San Jose, Ca) using a
custom-built nanoelectrospray ionization source. Electrospray
voltage of 2.0 kV was applied using a gold electrode via a liquid
junction upstream of the column. Spectra were scanned over the
range 400–1500 atomic mass units (amu). Automated peak
recognition, dynamic exclusion (45 seconds), and daughter ion
scanning of the top seven most intense ions were performed using
the Xcalibur v 1.4 SR1 data system (Thermo Fisher Scientific, San
Jose CA) [56]. The LC-LC-MS/MS analysis was repeated twice
for a total of three replicates and the data were combined.
Tandem MS spectra of peptides were analyzed with TurboSE-
QUESTTM v 3.1, a program that allows the correlation of
experimental tandem MS data with theoretical spectra generated
from known protein sequences [57]. The peak list for the search
was generated by Bioworks 3.1 (Thermo Fisher Scientific, San
Jose, CA) considering fully tryptic peptides with up to two missed
cleavages. Iodoacetamide derivatives of cysteines and oxidation of
methionines were specified as variable modifications. Parent
peptide mass error tolerances were set at 1.5 amu and fragment
ion mass tolerance set at 0.5 amu during the search. Preliminary
peptide identifications were made using the following Xcorr filters:
peptide precursor ions with a +1 charge having a Xcorr .1.8, +2
Xcorr .2.5 and +3 Xcorr .3.5. A deltaCn score .0.08 was also
used as filtering criteria for reliable matched peptide identification
[58], [59]. Tandem mass spectra were searched against mouse
genes encoding proteins with strong support of mitochondrial
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localization downloaded from the Broad Institute (http://www.
broadinstitute.org/pubs/MitoCarta/index.html), on July 27,
2012. At the time of the search this Mouse MitoCarta protein
database contained 1,173 entries. Additionally, the tandem mass
spectra were searched against Crustacea proteins downloaded
from NCBI on July 25, 2012 and appended with common
contaminant proteins (eg., human keratins, trypsin, etc). At the
time of the search this custom protein database contained 108,788
entries. The results were also validated using the search engine
X!Tandem [60], and displayed with Scaffold v 3.6.1 (Proteome
Software Inc., Portland OR), a program that relies on various
search engine results (i.e: Sequest, X!Tandem, MASCOT) and
which uses Bayesian statistics to reliably identify more spectra [61].
Sample Preparation for Artemia Franciscana
Mitochondria Lysed by Freeze/Thaw in Water
SDS was added to the lysate at a final concentration of 0.1%
and the lysate was sonicated for 5 sec using a probe sonicator.
Proteins were precipitated with acetone. After centrifugation at
16,000 g for 10 min the topmost lipid layer and the supernatant
were removed and discarded. The pellet was extracted with 8 M
urea/1 M guanadine HCl, sonicated as described above, and
subjected to a round of freeze/thawing. After centrifugation the
supernatant was saved and the pellet was extracted with 8 M urea
then centrifuged and the supernatant was removed and saved. The
combined supernatants were assayed for protein concentration
using the Pierce 660 nm reagent as per the manufacturer’s
instructions (Pierce, Rockford IL). The pellets from the processing
steps described above were dissolved in Laemmli sample buffer,
combined, and assayed for protein concentration as described
previously. One mg portions of the supernatant fraction were
either delipidated ([62] or cleaned up using the GE Healthcare 2-
D Clean-Up Kit as per the manufacturer’s instructions (GE
Healthcare, Piscataway NJ). The samples were fractionated by
SDS-PAGE; 10 g each of the delipidated sample, the kit-processed
sample, and the pellets was loaded on a 15% acrylamide Criterion
gel (BioRad, Hercules, CA), and after electrophoresis the gel was
stained with BioSafe Coomassie Blue (BioRad, Hercules CA).
Each gel lane was cut into 8 sections and the sections were digested
with trypsin following reduction with DTT and alkylation with
iodoacetamide, followed by peptide extraction from the gel
sections [55].
LC MS/MS Analysis of the Freeze/Thaw Lysed Artemia
Franciscana Mitochondria
LC-MS/MS analysis of trypsin-digested gel sections was carried
out using a LTQ Orbitrap Velos mass spectrometer (Thermo
Fisher Scientific, San Jose, CA) equipped with an Advion
nanomate ESI source (Advion, Ithaca, NY), following ZipTip
C18 sample clean up according to the manufacturer’s instructions
(Millipore, Billerica, MA). Peptides were eluted from a C18
precolumn (100-mm id62 cm, Thermo Fisher Scientific) onto an
analytical column (75-mm ID 6 10 cm, C18, Thermo Fisher
Scientific) using a 5% hold of solvent B (acetonitrile, 0.1% formic
acid) for 5 min, followed by a 5–7% gradient of solvent B over
5 min, 7–15% gradient of solvent B over 45 min, 15–35%
gradient of solvent B over 60 min, 35–40% gradient of solvent B
over 28 min, 40–85% gradient of solvent B over 5 min, 85% hold
of solvent B for 10 min and finally a return to 5% in 1 minute and
another 10 minute hold of 5% solvent B. All flow rates were
400 nl/min. Solvent A consisted of water and 0.1% formic acid.
Replicate runs were also performed using a shorter 125 minute RP
gradient (5% solvent B hold for 10 min, 5–20% gradient of solvent
B over 65 min, followed by a 20–35% gradient of solvent B over
25 min, 35% solvent B hold for 9 min, 35–95% gradient of solvent
B over 5 min, and finally by a 95% solvent B hold for another 5
minutes). Data dependent scanning was performed by the
Xcalibur v 2.1.0 software [56] using a survey mass scan at
60,000 resolution in the Orbitrap analyzer scanning mass/charge
(m/z) 400–1600, followed by collision-induced dissociation (CID)
tandem mass spectrometry (MS/MS) of the 14 most intense ions in
the linear ion trap analyzer. Precursor ions were selected by the
monoisotopic precursor selection (MIPS) setting with selection or
rejection of ions held to a +/210 ppm window. Dynamic
exclusion was set to place any selected m/z on an exclusion list
for 45 seconds after a single MS/MS. All MS/MS spectra were
searched against the protein databases as described above using
Thermo Proteome Discoverer 1.3 (Thermo Fisher Scientific)
considering fully tryptic peptides with up to two missed cleavages.
Iodoacetamide derivatives of cysteines and oxidation of methio-
nines were specified as variable modifications. Proteins were
identified at 99% confidence with XCorr score cut-offs [59] as
determined by a reversed database search. The protein and
peptide identification results were also visualized with Scaffold v
3.6.1 (Proteome Software Inc., Portland OR), a program that
relies on various search engine results (i.e.: Sequest, X!Tandem,
MASCOT) and which uses Bayesian statistics to reliably identify
more spectra [61]. Proteins were accepted that passed a minimum
of two peptides identified at 95% peptide confidence and 99.9%
protein confidence by the Peptide and Protein Profit algorithms,
respectively, within Scaffold.
Supporting Information
Table S1 ArAAC peptides identified by various mass-spectro-
metric methods. Samples were purified Artemia franciscana
mitochondria treated by various approaches as described in the
headers of the tables and detailed in Materials and Methods.
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Excel Sheet S1 Mass spectrometric analysis of Artemia mito-
chondria. Homologues of identified Sal1p, SCaMC-2 (isoform 1)
and SCaMC-3 are listed in six sheets, each representing the results
of an independent experiment.
(PDF)
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